Routine use of urodynamic testing for overactive bladder (OAB) did not improve patient-reported outcomes when combined with comprehensive clinical assessment (CCA), a large randomized trial showed.

Bright Uro Inc. this month received Food and Drug Administration approval for its first product, the Glean Urodynamics System. It’s the biggest milestone to date for the Irvine medical device maker ...

Derek Herrera, a former Marine who became paralyzed in 2012 while in combat, knows how unpleasant it is for many people to undergo bladder testing. “The test is uncomfortable and embarrassing; the ...